
BREAKING NEWS: Trump to Nominate Robert F. Kennedy Jr. as HHS Secretary
Controversial figure Robert F. Kennedy has been announced as Trump’s HHS Secretary nominee
Controversial figure Robert F. Kennedy has been announced as Trump’s HHS Secretary nominee
Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health join General Catalyst in $10.5 million funding round
Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect musculoskeletal and metabolic health for lifelong strength and well-being. The post Menopausal Women Deserve Better Obesity Care appeared first on MedCity News.
The Biden administration finalized several major Medicaid regulations with the intent of improving access to Medicaid services. Collectively, the rules span hundreds of pages of text, are extremely complex, and were set to be implemented over several years, with measurable increases in federal Medicaid spending. Overturning the rules would reduce regulation of managed care companies,…
El “One Big Beautiful Bill” del presidente Donald Trump recorta el gasto federal en los mercados de Medicaid y la Ley de Cuidado de Salud a Bajo precio (ACA) en aproximadamente $1.000 millones a lo largo de una década, según la Oficina de Presupuesto del Congreso (CBO), una entidad no partidista. Esto amenaza la salud…
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup. The post Why Intermountain Health Is Investing In AI for Clinical Data Abstraction appeared first on MedCity News.
Recommendations include real-time data sharing to give VA greater awareness of potential problems in system operations and prioritizing major performance incident response in a clear and consistent manner
The goal of MiHIN’s partnership with Beyond Lucid Technologies is to have seamless communication between ambulances and hospitals to streamline patient handoff
Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges. The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…